steve joined nea in 2015 as a venture partner on the healthcare team where he focuses on the medical device investing practice. prior to joining nea, steve served as medtronic’s senior vice president for medicine and technology and was a member of the medtronic executive committee for 14 years. by forging relationships with global technology partners and technical universities, he oversaw long term internal technology investments while participating in strategic corporate investments in emerging private companies. he also served as a member of the business development and strategy committee that approved all corporate acquisitions. during his tenure at medtronic steve served on more than 20 boards as a director or observer and built a strong and enduring profile for medtronic in the global venture capital and private equity communities. in addition to steve's nea responsibilites, he currently serves on the boards of alcyone lifesciences, baxter (nyse: bax), globallogic, montes archimedes acquisition company (nasdaq: maacu), peijia medical (hkg: 9996), shl medical, and sigilon therapeutics.
steve graduated summa cum laude from harvard and received his medical degree from yale; he completed his internship and residency at massachusetts general hospital. following medical school, he completed a fellowship in interventional cardiology at stanford and then served on the faculty at stanford and harvard medical schools and directed the invasive cardiology services at massachusetts general hospital and stanford.
February 4, 2018
June 20, 2017
February 7, 2017